President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Shares of Sangamo Therapeutics climbed after the genomic medicine company entered a licensing agreement with Eli Lilly for STAC-BBB. The stock rose 31% to 81 cents on volume of 3.1 million shares in ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

The White House Wednesday listed tariff rates for different countries. It didn’t take long for market observers to try and reverse engineer the formula.

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Eli Lilly is escalating its legal push to protect the exclusivity ... images, photos, graphics, graphs, charts, animations, ...

Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...

U.S. stock futures slipped on Monday night as the market awaited clarity from President Donald Trump regarding his tariff ...

Danish biotech giant Novo Nordisk is trading at an extremely attractive valuation — particularly relative to its main rival, ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...